Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance

D Hansen, A Astrup, S Toubro, Nicholas Finer, P Kopelman, J Hilsted, S Rössner, W Saris, L Van Gaal, W James, M Goulder, STORM Study Group

101 Citationer (Scopus)

Abstract

In this report we assess pre-treatment determinants of weight loss and maintenance outcome in The Sibutramine Trial of Obesity Reduction and Maintenance (STORM), a 2 y randomized, double-blind, placebo-controlled, European multicenter study examining the effect of sibutramine (Sib) on inducing and maintaining weight loss in obese subjects.
OriginalsprogEngelsk
TidsskriftInternational Journal of Obesity
Vol/bind25
Udgave nummer4
Sider (fra-til)496-501
Antal sider6
ISSN0307-0565
DOI
StatusUdgivet - apr. 2001

Fingeraftryk

Dyk ned i forskningsemnerne om 'Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance'. Sammen danner de et unikt fingeraftryk.

Citationsformater